BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 38253425)

  • 21. IL-17, GAL-10, and TGF-β are promising noninvasive biomarkers of pediatric eosinophilic esophagitis.
    Votto M; Naso M; De Amici M; Castagnoli R; De Silvestri A; De Filippo M; Testa G; Marseglia GL; Licari A
    Pediatr Allergy Immunol; 2024 Mar; 35(3):e14111. PubMed ID: 38512103
    [No Abstract]   [Full Text] [Related]  

  • 22. A Novel, Noninvasive Method to Diagnose Active Eosinophilic Esophagitis, Combining Clinical Data and Oral Cavity RNA Levels.
    Sebastian-Delacruz M; Garcia-Etxebarria K; Bilbao JR; Lucendo AJ; Bujanda L; Castellanos-Rubio A
    Clin Gastroenterol Hepatol; 2024 Mar; 22(3):656-658.e3. PubMed ID: 37543102
    [No Abstract]   [Full Text] [Related]  

  • 23. Gastrointestinal Eosinophilic Diseases: Updates on Eosinophilic Esophagitis and Eosinophilic Gastrointestinal Diseases.
    Furuta GT; Atkins D
    Immunol Allergy Clin North Am; 2024 May; 44(2):xix-xx. PubMed ID: 38575233
    [No Abstract]   [Full Text] [Related]  

  • 24. Eosinophilic oesophagitis: Significantly increasing prevalence in a tertiary London paediatric gastro-intestinal and allergy department.
    Buck E; Ocholi A; Moolenschot KL; Kapoor R; Perkin M; Wells R
    Clin Res Hepatol Gastroenterol; 2022; 46(6):101958. PubMed ID: 35609822
    [No Abstract]   [Full Text] [Related]  

  • 25. Young adults with eosinophilic oesophagitis.
    Arch Dis Child; 2023 Feb; 108(2):93. PubMed ID: 36657800
    [No Abstract]   [Full Text] [Related]  

  • 26. Eosinophilic Gastrointestinal Disorders.
    Fahey LM; Liacouras CA
    Pediatr Clin North Am; 2017 Jun; 64(3):475-485. PubMed ID: 28502433
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mast cell-pain connection in eosinophilic esophagitis.
    Zhang S; Shoda T; Aceves SS; Arva NC; Chehade M; Collins MH; Dellon ES; Falk GW; Gonsalves N; Gupta SK; Hirano I; Khoury P; Leung J; Spergel AKR; Spergel JM; Wechsler JB; Yang GY; Furuta GT; Rothenberg ME;
    Allergy; 2022 Jun; 77(6):1895-1899. PubMed ID: 35175645
    [No Abstract]   [Full Text] [Related]  

  • 28. Modifying the natural history of gastrointestinal diseases in Europe as a result of early diagnosis: From eosinophilic esophagitis to inflammatory bowel disease.
    Molina-Infante J; Rodríguez-Lago I
    United European Gastroenterol J; 2022 Sep; 10(7):612-613. PubMed ID: 35614522
    [No Abstract]   [Full Text] [Related]  

  • 29. Should children with immunoglobulin E-mediated food allergy be screened for eosinophilic esophagitis?
    Capucilli P; Ramsey A; Tuong LA; Mustafa SS
    Ann Allergy Asthma Immunol; 2022 Jun; 128(6):724-725. PubMed ID: 35292363
    [No Abstract]   [Full Text] [Related]  

  • 30. Eosinophilic gastrointestinal diseases make a name for themselves: A new consensus statement with updated nomenclature.
    Wright BL; Schwartz JT; Ruffner MA; Furuta GT; Gonsalves N; Dellon ES; Aceves SS
    J Allergy Clin Immunol; 2022 Aug; 150(2):291-293. PubMed ID: 35649464
    [No Abstract]   [Full Text] [Related]  

  • 31. Eosinophilic Gastrointestinal Diseases Beyond Eosinophilic Esophagitis.
    Dellon ES
    Am J Gastroenterol; 2022 May; 117(5):697-700. PubMed ID: 35081543
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A subset of patients with eosinophilic esophagitis demonstrate delayed gastric emptying.
    Khosh-Hemmat E; Babbel J; Chaiboonma K; Dohil R; Aceves SS
    J Allergy Clin Immunol Pract; 2022 Oct; 10(10):2764-2767.e1. PubMed ID: 35779782
    [No Abstract]   [Full Text] [Related]  

  • 33. Health-Related Quality of Life in Patients with Eosinophilic Esophagitis.
    van Klink ML; Bredenoord AJ
    Immunol Allergy Clin North Am; 2024 May; 44(2):265-280. PubMed ID: 38575222
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Eosinophilic oesophagitis and type 2 inflammation multimorbidity: an opportunity for biologic treatment.
    Franceschini L; Farsi A
    Lancet Gastroenterol Hepatol; 2022 Sep; 7(9):787-788. PubMed ID: 35932768
    [No Abstract]   [Full Text] [Related]  

  • 35. Emerging Therapies for Eosinophilic Gastrointestinal Diseases.
    Peterson K; Safroneeva E; Schoepfer A
    J Allergy Clin Immunol Pract; 2021 Sep; 9(9):3276-3281. PubMed ID: 34343695
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Eosinophilic gastrointestinal disease below the belt.
    Pesek RD; Rothenberg ME
    J Allergy Clin Immunol; 2020 Jan; 145(1):87-89.e1. PubMed ID: 31669097
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Eosinophilic esophagitis: Shifting immune complexity beyond the eosinophil.
    Lewis NE; Aceves SS
    J Allergy Clin Immunol; 2024 Mar; 153(3):669-671. PubMed ID: 38262501
    [No Abstract]   [Full Text] [Related]  

  • 38. GATA-3 and T-bet as diagnostic markers of non-esophageal eosinophilic gastrointestinal disease.
    Neely JL; Reimers A; Taylor S; Garg S; Masuda MY; Schroeder S; Wright BL; Doyle AD
    Allergy; 2022 Mar; 77(3):1042-1044. PubMed ID: 34735725
    [No Abstract]   [Full Text] [Related]  

  • 39. Disease associations in eosinophilic oesophagitis and oesophageal eosinophilia.
    Lucendo AJ
    Best Pract Res Clin Gastroenterol; 2015 Oct; 29(5):759-769. PubMed ID: 26552775
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical and Pathological Correlation in Concomitant Celiac Disease and Eosinophilic Esophagitis Suggests Separate Etiologies.
    Castrodad-Rodríguez CA; Cheng J; Westerhoff M; Liang GH; Lin J; Nalbantoglu I; Hu S; Sekhri R; Panarelli NC
    Int J Surg Pathol; 2024 Feb; 32(1):27-34. PubMed ID: 37050846
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.